International Patent: ANTI-MUC16 ANTIBODIES AND USES THEREOF

GENEVA, July 18 -- WUXI BIOLOGICS (SHANGHAI FX) CO., LTD. filed a patent application (CN2025/142128) for “ANTI-MUC16 ANTIBODIES AND USES THEREOF”. With publication no. WO/2026/149136, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/30

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....